PARABILIS MEDICINES Trademark

Trademark Overview


On Thursday, September 12, 2024, a trademark application was filed for PARABILIS MEDICINES with the United States Patent and Trademark Office. The USPTO has given the PARABILIS MEDICINES trademark a serial number of 98746837. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 21, 2025. This trademark is owned by Fog Pharmaceuticals, Inc.. The PARABILIS MEDICINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

drug discovery services; Scientific research and development; providing information in the field of scientific research and development in the biotechnology and pharmaceutical fields; scientific research and development in the field of biotechnology and pharmaceuticals

house mark for pharmaceutical preparations for use in connection with the prevention and treatment of cancer, inflammatory conditions, immunological disorders, neoplastic conditions, rare genetic diseases, cardiovascular conditions, infectious diseases, and neurological conditions; biomedical compounds for medical purposes, namely, peptides and miniproteins and cell-penetrating peptides and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions
parabilis medicines

General Information


Serial Number98746837
Word MarkPARABILIS MEDICINES
Filing DateThursday, September 12, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 21, 2025

Trademark Statements


NOT AVAILABLEMEDICINES
Goods and Servicesdrug discovery services; Scientific research and development; providing information in the field of scientific research and development in the biotechnology and pharmaceutical fields; scientific research and development in the field of biotechnology and pharmaceuticals
Goods and Serviceshouse mark for pharmaceutical preparations for use in connection with the prevention and treatment of cancer, inflammatory conditions, immunological disorders, neoplastic conditions, rare genetic diseases, cardiovascular conditions, infectious diseases, and neurological conditions; biomedical compounds for medical purposes, namely, peptides and miniproteins and cell-penetrating peptides and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 12, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePARABILIS MEDICINES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02140

Party NamePARABILIS MEDICINES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02140

Party NameFog Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events


Event DateEvent Description
Thursday, September 12, 2024NEW APPLICATION ENTERED
Thursday, September 12, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, November 6, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, January 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 12, 2025ASSIGNED TO EXAMINER
Saturday, March 22, 2025NON-FINAL ACTION WRITTEN
Saturday, March 22, 2025NON-FINAL ACTION E-MAILED
Saturday, March 22, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 9, 2025ASSIGNED TO LIE
Wednesday, April 9, 2025ASSIGNED TO LIE
Wednesday, April 9, 2025ASSIGNED TO LIE
Friday, May 2, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, May 2, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, September 16, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 16, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 23, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 15, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 21, 2025PUBLISHED FOR OPPOSITION
Tuesday, October 21, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED